Evidence map›Paper›PMID 27265207›Full record

ArticleScientific reports2016

A carnosine intervention study in overweight human volunteers: bioavailability and reactive carbonyl species sequestering effect.

Luca Regazzoni, Barbora de Courten, Davide Garzon, Alessandra Altomare, Cristina Marinello, Michaela Jakubova, Silvia Vallova, Patrik Krumpolec, Marina Carini, Jozef Ukropec and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Carnosine supplementation improves cognitive outcomes in younger participants of the NEAT trial.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Trial
  3. Trial
  4. Trial
  5. Article
  6. Histidine-Containing Dipeptides in Obesity and Cardiometabolic Health: A Systematic Scoping Review.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Luca RegazzoniDepartment of Pharmaceutical Sciences, Università degli Studi di Milano, Milan, Italy.
Barbora de CourtenMonash Centre for Health, Research and Implementation, School of Public health and Preventive Medicine, Melbourne, Australia.
Davide GarzonDepartment of Pharmaceutical Sciences, Università degli Studi di Milano, Milan, Italy.
Alessandra AltomareDepartment of Pharmaceutical Sciences, Università degli Studi di Milano, Milan, Italy.
Cristina MarinelloDepartment of Pharmaceutical Sciences, Università degli Studi di Milano, Milan, Italy.
Michaela JakubovaInstitute of Pathological Physiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
Silvia VallovaInstitute of Pathological Physiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
Patrik KrumpolecInstitute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
Marina CariniDepartment of Pharmaceutical Sciences, Università degli Studi di Milano, Milan, Italy.
Jozef UkropecInstitute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
Barbara UkropcovaInstitute of Pathological Physiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
Giancarlo AldiniDepartment of Pharmaceutical Sciences, Università degli Studi di Milano, Milan, Italy.
University of Milan · ITComenius University Bratislava · SKInstitute of Experimental Endocrinology of the Slovak Academy of Sciences · SKMonash Health · AUSlovak Academy of Sciences · SK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carnosine is a natural dipeptide able to react with reactive carbonyl species, which have been recently associated with the onset and progression of several human diseases. Herein, we report an intervention study in overweight individuals. Carnosine (2 g/day) was orally administered for twelve weeks in order to evaluate its bioavailability and metabolic fate. Two carnosine adducts were detected in the urine samples of all subjects. Such adducts are generated from a reaction with acrolein, which is one of the most toxic and reactive compounds among reactive carbonyl species. However, neither carnosine nor adducts have been detected in plasma. Urinary excretion of adducts and carnosine showed a positive correlation although a high variability of individual response to carnosine supplementation was observed. Interestingly, treated subjects showed a significant decrease in the percentage of excreted adducts in reduced form, accompanied by a significant increase of the urinary excretion of both carnosine and carnosine-acrolein adducts. Altogether, data suggest that acrolein is entrapped in vivo by carnosine although the response to its supplementation is possibly influenced by individual diversities in terms of carnosine dietary intake, metabolism and basal production of reactive carbonyl species.

Indexed as

AcroleinBiological AvailabilityCarnosineHumansMaleObesityOverweightOxidative StressAcroleinCarnosine

Identifiers

PMID27265207
PMCPMC4893669
OpenAlexW2469273189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.